Zajec, Marina

English

EUR Research Repository

EUR Research Information PortalMultiple Myeloma: Towards clinical monitoring of minimal residual disease using massspectrometryPublication status and date:Published: 16/10/2020Document VersionOther versionCitation for the published version (APA):Zajec, M. (2020). Multiple Myeloma: Towards clinical monitoring of minimal residual disease using mass spectrometry.[Doctoral Thesis, Erasmus University Rotterdam]. Erasmus Universiteit Rotterdam (EUR).Link to publication on the EUR Research Information PortalTerms and Conditions of UseExcept as permitted by the applicable copyright law, you may not reproduce or make this material available to any third partywithout the prior written permission from the copyright holder(s). Copyright law allows the following uses of this materialwithout prior permission:            • you may download, save and print a copy of this material for your personal use only;            • you may share the EUR portal link to this material.In case the material is published with an open access license (e.g. a Creative Commons (CC) license), other uses may beallowed. Please check the terms and conditions of the specific license.Take-down policyIf you believe that this material infringes your copyright and/or any other intellectual property rights, you may request itsremoval by contacting us at the following email address: openaccess.library@eur.nl. Please provide us with all the relevantinformation, including the reasons why you believe any of your rights have been infringed. In case of a legitimate complaint,we will make the material inaccessible and/or remove it from the website.Propositions associated with the thesis   MULTIPLE MYELOMA Towards clinical monitoring of minimal residual disease using mass spectrometry   1. Mass spectrometry is at least 100 times more sensitive for M-protein detection than conventional serum diagnostics. (this thesis) 2. Mass spectrometry M-protein data complements plasma cell data for minimal residual disease evaluation. (this thesis) 3. M-protein bands, isolated from serum protein electrophoretic gels, can be used as the starting material for mass spectrometry analysis. (this thesis) 4. Daratumumab penetrates the blood-brain barrier with low efficiency. (this thesis) 5. Mass spectrometry has the potential to guide clinical decision-making in multiple myeloma. (this thesis) 6. Palliative care improves the quality of life of the patient, their family, and friends. (Hoerger M. et al., Ann Behav Med, 2019; Rothschild C.B. et al., Curr Opin Pediatr, 2020) 7. The first step towards achieving gender equality is recognizing that gender inequality exists and that it affects the lives of all of us. (Waaijer C.J.F. et al., Plos One, 2016; Gates M., Lancet, 2019) 8. Uptake of paternity leave should be normalized in order to give fathers a more prominent role in raising and caring for their child. (Storey A.E. et al., Horm Behav, 2020; Henry J.B. et al., J Sch Nurs, 2020) 9. Increasing diversity in the workplace generates ideas and innovation. (Shannon G. et al., Lancet, 2019; Harrison-Bernard L.M., Adv Physiol Educ, 2020) 10. Good mentoring is an alliance where both the mentor and the mentee learn and teach. (McBurney E.I., Clin Dermatol, 2015; Waters L. et al., Adv Health Sci Educ Theory Pract, 2018) 11. May your whole body be filled with the dim light of the stars! (Šimić, Antun Branko. “Warning”.) Pusti da cijelog tebe prođe blaga svjetlost zvijezda! (Šimić, Antun Branko. “Opomena”.)    by Marina Zajec 

Multiple Myeloma: Towards clinical monitoring of minimal residual disease using mass spectrometry

https://pure.eur.nl/ws/files/46492170/propositions-Marina-Zajec.pdf

Multiple Myeloma: Towards clinical monitoring of minimal residual disease using mass spectrometry

Abstract

Similar works

Full text

Available Versions

EUR Research Repository